| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:2145.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Department of Cardiology, Cardiovascular Research Institute Maastricht, Academic Hospital Maastricht, Netherlands.
Correspondence to M.A. Vos, PhD, Department of Cardiology, Cardiovascular Research Institute Maastricht, Academic Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands. E-mail m.vos{at}cardio.azm.nl
| Abstract |
|---|
|
|
|---|
Methods and ResultsSteady-state and dynamic (fast pacing: 1 to 68 stimuli) left and right ventricular systolic and diastolic parameters were determined by positive and negative inotropic interventions at acute AVB and CAVB. Concomitantly, left and right ventricular endocardial monophasic action potentials were registered. In CAVB, all systolic contractile parameters were markedly increased, resulting in preserved cardiac output. The increase was most pronounced at low heart rates, altering the force-frequency response. At both acute AVB and CAVB, the degree of potentiation of cardiac function with pacing was dependent on the number of stimuli and showed a maximum at 8 to 13 stimuli. With CAVB, this potentiation curve was shifted upward, and it was only then that pacing resulted in DADs (in 8 of 10 dogs) and ectopic beats (EBs, in 6 of 10 dogs). The incidence of EBs in relation to the number of stimuli also had a maximum at 8 to 13 stimuli. Ouabain increased the incidence of DADs and EBs, whereas the negative inotropic interventions prevented them completely.
ConclusionsThe alterations responsible for improvement in systolic contractile function in CAVB dogs predispose the hypertrophied heart to DAD-dependent triggered arrhythmias during positive inotropic interventions.
Key Words: tachycardia hypertrophy contractility electrophysiology
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Pacing Protocols, Interventions, and Data Analysis
At AAVB and CAVB, the FF protocols (3 minutes of steady state)
consisted of cycle lengths (CLs) of 300, 575±25 (equal to SR), 750,
1000, and 1250 ms. The PESP protocol consisted of a basic rhythm of 600
ms, which was interrupted every 20 beats by extrastimuli with
decreasing coupling intervals from 550 to 250 ms. The PSP trains were
delivered with an interstimulus interval of 300 ms and 1 to 68 stimuli.
Three interventions were performed, after which PSP was repeated: at
AAVB and CAVB, (1) 20 µg/kg ouabain IV was given (n=6) and (2)
fixed-rate pacing (FRP) with the SR CL (520±40 ms, n=5) was performed
with constant recovery interval. The third intervention, ryanodine (10
µg · kg-1
· 10 min-1), was
administered only to 4 DAD-susceptible CAVB dogs. Pacing was performed
from either the LV electrode (FF and PESP) or the RV MAP (PSP). By use
of a software program, data were analyzed offline: LV and RV
end-systolic pressure (ESP), end-diastolic pressure
(EDP), and +dP/dtmax. From the ECG, CL
idioventricular rhythm, CL PP interval, and QT time were
determined. To correlate the functional adaptations with TA, we
measured (1) coupling interval of the first beat postpacing, (2) LV and
RV action potential duration of the MAP at 100% repolarization (MAPD),
and (3) LV and RV +dP/dt before each pacing train and of beats 1 to 3
postpacing, either spontaneous, ectopic, or paced. DADs were defined in
the MAP as an afterpotential with a diastolic slope of
10
mV/s. EBs were defined as ventricular activations with a
postpacing interval <600 ms. VT was defined as
5 consecutive EBs. We
refer to inducible dogs as those that responded with either EBs or
VT.
Heart Weight
We confirmed that the CAVB dogs had (biventricular)
hypertrophy: the ratio of heart to body weight was
11.5±2.1 g/kg. Slicing the heart in a subset of dogs (n=6) revealed
5.8±1.2 and 2.4±0.3 g/kg for the LV and RV, respectively.
Statistics
Data are presented as mean±SD unless otherwise stated.
Statistical tests included (P
0.05) repeated ANOVA followed
by Bonferronis t test, 2-tailed Students t
test for unpaired events,
2 testing, and
logarithmic regression analysis.
| Results |
|---|
|
|
|---|
|
|
PESP and PSP at Baseline
At AAVB and CAVB, the PESP protocols resulted in an increase in
+dP/dtmax when the extrastimulus interval was
decreased. The values obtained were higher at CAVB (Figure 1
, bottom). At all time points, a fast pacing train resulted in a clear
potentiation of cardiac function, which disappeared within 3 to 5 beats
(Table 2
and Figure 2
). This PSP was dependent on the number
of stimuli: +dP/dtmax increased up to a maximum
at
10 beats (Figure 3
) and declined
with a further increase in the stimuli (for details see Figure 5
). These LV and RV PSP curves were comparable between SR and
AAVB but were clearly shifted upward at CAVB.
|
|
|
|
Triggered Ventricular Arrhythmias at
Baseline
At AAVB, pacing never resulted in the induction of DADs or EBs. In
contrast, at CAVB, similar pacing trains induced EBs in 6 of 10
(P<0.05) and VT in 1 of 10 dogs, which coincided with DADs
in the MAPs in 8 of 10 dogs (P<0.05). An example is shown
in Figure 2
. The number of induced EBs also varied depending on
the number of stimuli (Figures 4
and 5
). Most EBs were induced after 5 to 13
stimuli, which corresponded with the highest postpacing LV +dP/dt.
|
Inotropic Interventions Modulating Arrhythmias
At AAVB, the positive inotropic effect of ouabain or FRP did not
result in the induction of DADs or EBs (Table 3
). At CAVB, in contrast, ouabain
increased the induction of arrhythmias (Figures 5
and 6
), which was accompanied by a sawtooth
appearance in the potentiation curve (Figure 5
, top right). The
induction of EBs was broadened when the different numbers of stimuli
were compared (bottom right), and the numbers of EBs were increased
(Table 3
), sometimes resulting in VT (Figure 6
).
|
|
At CAVB, the negative inotropic effects of FRP (Table 3
) or
ryanodine (data not shown) were accompanied by prevention of all DADs
and triggered EBs.
To describe the PSP curve, we determined the postpacing LV +dP/dt of
any first postpacing beat, independent of coupling interval or
activation sequence. Figure 7
shows PSP
of single pacing trains subdivided for AAVB and CAVB and for their
responses (EB+ and EB-) in relation to the prepacing inotropic values.
There was a positive relation
(r2=0.57) between potentiation and
prepacing LV +dP/dt. Importantly, the different arrhythmic responses
could not be discriminated on the basis of absolute LV +dP/dt or PSP,
suggesting interindividual differences.
|
| Discussion |
|---|
|
|
|---|
The CAVB Dog: Biventricular Compensated
Contractile Function
Cardiac hypertrophy is an adaptation to mechanical
overload of any cause. Whether this adaptation is able to maintain its
contractile performance in time or whether there will be
degeneration to congestive heart failure is still not clear. To
quantify heart failure, numerous parameters have
been developed at the integrative, (multi)cellular, and molecular
level. In the nonfailing myocardium, FF and PESP are
well-known phenomena that are decreased in the early stages of heart
failure.10 11 12 13 14
In the CAVB dog, both ventricles perform adequately under baseline as
well as more demanding conditions (Figures 1
and 3
). The
FF response in the CAVB dog is altered, however (Figure 1
):
increasing the rate is no longer associated with an increase in LV or
RV +dP/dtmax. The FF curve, however, is always
increased with regard to AAVB and never reaches the data obtained in
canine heart failure.12 15 16 Interpretation of this
finding is complex, but rate-dependent measurements of cell shortening
and calcium transients in isolated myocytes confirm that this is an
intrinsic property of the cells.7 The possible role of an
increased Na-Ca exchange current for improved contractile
performance at slow rates is discussed in the accompanying
article.7
PESP is also maintained during CAVB (Figure 1
). PSP was
seen during SR, AAVB, and CAVB (Figure 3
), and its magnitude was
dependent on the number of stimuli (Figures 3
and 5
) and
on the prepacing inotropic state (Figure 7
). The highest PSP
values were obtained at CAVB after short pacing trains consisting of 5
to 13 stimuli. To the best of our knowledge, we are the first to
describe PSP in vivo. Because this curve remained present under all
conditions tested, including FRP, we can exclude alterations in
ventricular filling secondary to variations in the interval
as the underlying mechanism. It appears that this PSP curve is
intrinsic to the myocardium. All these findings are
indicative of compensated contractile function in the CAVB dogs at 6 to
10 weeks.
TAs and Potentiation of Contractile Function
Electrical remodeling in the CAVB dog5 6 consists of
an increase in repolarization times that exceeds the expected
lengthening on the basis of rate and that is not uniform, leading to an
increase in interventricular dispersion (Table 2
).
This dissimilar MAPD lengthening is caused by specific
ventricular alterations in ionic channel
function.7 17 Potential stimuli may include bradycardia,
hypertrophy, and/or the alterations in calcium homeostasis.
Synergistic effects could explain why our MAPD increase exceeds those
reported so far in canine LVH.18
The PESP protocols never proved to be arrhythmic. Short-lasting, fast
pacing trains, however, resulted in EBs in the majority of CAVB dogs
but not in those with AAVB (Tables 2
and 3
). The occurrence of
EBs coincided with DAD registration on the MAP (Figures 2
, 4
, and 6
), thereby indicating triggered activity as the
underlying mechanism. Curves of potentiation and of incidence of EBs
were similar, suggesting a common origin. The dynamic changes in
calcium handling may temporarily create an arrhythmogenic window of
calcium overload in the CAVB dog, during which the DADs and EBs occur.
This hypothesis was studied further by use of different interventions
that modulate the inotropic state. At AAVB, 2 positive inotropic
interventions (ouabain and FRP) did not lead to induction of any
arrhythmia. The highest PSP obtained, however, was far less
than the baseline CAVB value (Table 3
). The same therapeutic
dosage of ouabain in CAVB increased the number of pacing trains that
responded with EBs, and VT even occurred (Figures 5
and 6
). The negative inotropic interventions at CAVB (FRP and
ryanodine) caused prevention of the induction of all DADs and EBs. The
block of the sarcoplasmic reticulum calcium release channel by
ryanodine has been described to abolish DAD-related EBs.19
Thus, the CAVB heart is more susceptible to DAD-dependent
arrhythmias under circumstances that demand higher contractile
performance, in which the increased Na-Ca exchange current can
be of great importance.7 It is unclear whether this
arrhythmogenic potential is related to the remodeling processes or
whether it is purely due to the (maximal attained) inotropism. In the
latter, individual parameters such as the basal inotropic
state, maximal amount of potentiation, contractile reserve, and
threshold at which the sarcoplasmic reticulum spontaneously releases
calcium have to be included. Whereas the prepacing inotropic state has
a relation with maximal PSP and the occurrence of EBs, single-train
analysis (Figure 7
) did not allow prediction of the
occurrence of EBs, suggesting that the inotropic state is not the
single determinant.
In vitro, an increased propensity of hypertrophied myocardium to DAD-dependent TAs has been described.20 21 In these studies, stimulation alone resulted rather infrequently in DADs, whereas combining pacing with adrenergic stimulation frequently induced TAs. Because we studied intact animals, local activity of the autonomic nervous system might be related to the observed occurrence of DADs and related EBs.
Clinical Implications
Extrapolation from animal data to humans must be done with great
caution. Both hypertrophy22 and heart
failure23 are known to predispose the human heart to
ventricular arrhythmias and sudden cardiac death.
The exact mechanisms involved are not elucidated, although prolongation
of the APD has been described consistently and changes in
calcium handling have been implicated,23 suggesting TA as
a contributing mechanism. Whether DADs occur with maximal inotropism
(hypertrophy) or when the function is severely depressed
(heart failure) can only be answered when combined, detailed
information about the contractile performance and the
arrhythmias is available and possible confounding factors, like
ischemia, are excluded. This is most easily obtained in animal
models. However, arrhythmogenic information has been limited to only a
few studies, performed predominantly in heart
failure.16 18 24 25
Limitations
Because we measured at only 2 time points, we cannot exclude a
time-specific arrhythmogenic response. Moreover, AAVB and CAVB resemble
2 different neurohumoral situations that can influence the results. In
AAVB, compensation mechanisms have been activated, whereas at 6
weeks of CAVB, all plasma neurohumoral parameters have
returned to baseline.5 Second, we do not know to what
extent the observed phenomena actually relate to the different
remodeling processes. Other factors can also play a role in the
alterations in contractile function, including the sensitivity of the
cardiac contractile proteins and the interstitial tissue of
the myocardium. Third, we have concentrated on the
initiation of the arrhythmia by DADs, thereby excluding other
mechanisms.
In conclusion, the alterations accompanying the improvement in contractile function in the CAVB dog predispose the heart to DAD-dependent TA.
| Acknowledgments |
|---|
Received March 6, 2000; revision received May 31, 2000; accepted May 31, 2000.
| References |
|---|
|
|
|---|
2.
De Ferrari GM, Viola MC, DAmato E, et
al. Distinct patterns of calcium transients during early
and delayed afterdepolarizations induced by isoproterenol in
ventricular myocytes. Circulation. 1995;91:25102515.
3.
De Groot SHM, Vos MA, Gorgels APM, et al. Combining
monophasic action potential recordings with pacing to
demonstrate delayed afterdepolarizations and triggered
arrhythmias in the intact heart. Circulation. 1995;92:26972704.
4.
Vos MA, Gorgels APM, Leunissen HDM, et al.
Significance of the number of stimuli to induce triggered
arrhythmias in the intact heart. Circ Res. 1991;68:3844.
5.
Vos MA, de Groot SHM, Verduyn SC, et al. Enhanced
susceptibility for acquired torsade de pointes arrhythmias in
the dog with chronic, complete AV block is related to cardiac
hypertrophy and electrical remodeling.
Circulation. 1998;98:11251135.
6.
Volders PGA, Sipido KR, Vos MA, et al. Cellular basis
of biventricular hypertrophy and
arrhythmogenesis in dogs with chronic, complete AV-block and acquired
torsade de pointes. Circulation. 1998;98:11361147.
7.
Sipido KR, Volders PGA, de Groot SHM, et al. Enhanced
Ca2+ release and Na/Ca exchange activity in
hypertrophied canine ventricular myocytes.
Circulation. 2000;102:21372144.
8. Aubert AE. In vivo comparison between two tip pressure transducer systems. Int J Clin Monit Comput. 1995;12:7783.[Medline] [Order article via Infotrieve]
9. Conway J, Lund-Johansen P. Thermodilution method for measuring cardiac output. Eur Heart J. 1990;11:I17I20.
10.
Liu CP, Ting CT, Lawrence W, et al. Diminished
contractile response to increased heart rate in intact human left
ventricular hypertrophy.
Circulation. 1993;88:18931906.
11.
Hasenfuss G, Holubarsch C, Hermann HP, et al. Influence
of the force frequency relationship on haemodynamics and left
ventricular function in patients with non-failing hearts
and in patients with dilated cardiomyopathy.
Eur Heart J. 1994;15:164170.
12.
Vatner DE, Sato N, Kiuchi K, et al. Decrease in
myocardial ryanodine receptors and altered excitation-contraction
coupling early in the development of heart failure.
Circulation. 1994;90:14231430.
13.
Burkhoff D, Yue DT, Franz MR, et al. Quantitative
comparison of the force-interval relationships of the canine right and
left ventricles. Circ Res. 1984;54:468473.
14. ter Keurs HEDJ, Schouten VJA, Bucx JJ, et al. Excitation-contraction coupling in myocardium: implications of calcium release and Na+-Ca2+ exchange. Can J Physiol. 1987;65:619626.[Medline] [Order article via Infotrieve]
15.
Hittinger L, Patrick T, Ihara T, et al. Exercise
induces cardiac dysfunction in both moderate, compensated and severe
hypertrophy. Circulation. 1994;89:22192231.
16.
Sabbah HN, Goldberg AD, Schoels W, et al. Spontaneous
and inducible ventricular arrhythmias in a canine
model of chronic heart failure: relation to
hemodynamics and sympathoadrenergic activation.
Eur Heart J. 1992;13:15621572.
17.
Volders PGA, Sipido KR, Vos MA, et al. Downregulation
of delayed rectifier K+ current in dogs with
chronic complete atrioventricular block and acquired
torsade de pointes. Circulation. 1999;100:24552461.
18. Ben-David J, Zipes DP, Ayers GM, et al. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644. J Am Coll Cardiol. 1992;20:15761584.[Abstract]
19.
Hadju S, Leonard E. Action of ryanodine on mammalian
cardiac muscle: effects on contractility, and reversal
of digitalis induced ventricular arrhythmias.
Circ Res. 1961;9:12911298.
20. Aronson RS, Ming Z. Cellular mechanisms of arrhythmias in the hypertrophied and failing myocardium. Circulation. 1993;87(suppl VII):VII-76VII-83.
21. Charpentier F, Baudet S, Le Marec H. Triggered activity as a possible mechanism for arrhythmias in ventricular hypertrophy. Pacing Clin Electrophysiol. 1991;14:17351741.[Medline] [Order article via Infotrieve]
22. Levy D. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. Ann Intern Med. 1988;108:713.
23.
Tomaselli GF, Marban E.
Electrophysiological remodeling in
hypertrophy and heart failure. Cardiovasc Res. 1999;42:270283.
24. Pak PH, Nuss HB, Tunin RS, et al. Repolarization abnormalities, arrhythmia and sudden cardiac death in canine tachycardia-induced cardiomyopathy. J Am Coll Cardiol. 1997;30:576584.[Abstract]
25.
Pogwizd SM. Non-reentrant mechanisms underlying
spontaneous ventricular arrhythmias in a model of
nonischemic heart failure in rabbits. Circulation. 1995;92:10341048.
This article has been cited by other articles:
![]() |
T. P. Nguyen, D. W. Wang, T. H. Rhodes, and A. L. George Jr Divergent Biophysical Defects Caused by Mutant Sodium Channels in Dilated Cardiomyopathy With Arrhythmia Circ. Res., February 15, 2008; 102(3): 364 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bito, F. R. Heinzel, L. Biesmans, G. Antoons, and K. R. Sipido Crosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling Cardiovasc Res, January 15, 2008; 77(2): 315 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K.G. Winckels, M. B. Thomsen, P. Oosterhoff, A. Oros, J. D.M. Beekman, N. J.M. Attevelt, L. Kretzers, and M. A. Vos High-Septal Pacing Reduces Ventricular Electrical Remodeling and Proarrhythmia in Chronic Atrioventricular Block Dogs J. Am. Coll. Cardiol., August 28, 2007; 50(9): 906 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gizurarson, M. Lorentzon, T. Ramunddal, F. Waagstein, L. Bergfeldt, and E. Omerovic Effects of complete heart block on myocardial function, morphology, and energy metabolism in the rat Europace, June 1, 2007; 9(6): 411 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Antoons, P. G. A. Volders, T. Stankovicova, V. Bito, M. Stengl, M. A. Vos, and K. R. Sipido Window Ca2+ current and its modulation by Ca2+ release in hypertrophied cardiac myocytes from dogs with chronic atrioventricular block J. Physiol., February 15, 2007; 579(1): 147 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Thomsen, A. Oros, M. Schoenmakers, J. M. van Opstal, J. N. Maas, J. D.M. Beekman, and M. A. Vos Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation Cardiovasc Res, February 1, 2007; 73(3): 521 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peschar, K. Vernooy, R. N Cornelussen, X. A.A.M Verbeek, R. S Reneman, M. A Vos, and F. W Prinzen Structural, electrical and mechanical remodeling of the canine heart in AV-block and LBBB Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D61 - D65. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Thomsen, P. G. A. Volders, M. Stengl, R. L. H. M. G. Spaatjens, J. D. M. Beekman, U. Bischoff, M. A. Kall, K. Frederiksen, J. Matz, and M. A. Vos Electrophysiological Safety of Sertindole in Dogs with Normal and Remodeled Hearts J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 776 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schoenmakers, C. Ramakers, J. M. van Opstal, J. D.M. Leunissen, C. Londono, and M. A. Vos Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog Cardiovasc Res, August 1, 2003; 59(2): 351 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peschar, K. Vernooy, W. Y.R Vanagt, R. S Reneman, M. A Vos, and F. W Prinzen Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles Cardiovasc Res, June 1, 2003; 58(3): 510 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Pogwizd, K. R Sipido, F. Verdonck, and D. M Bers Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis Cardiovasc Res, March 15, 2003; 57(4): 887 - 896. [Full Text] [PDF] |
||||
![]() |
F. Verdonck, P. G.A Volders, M. A Vos, and K. R Sipido Increased Na+ concentration and altered Na/K pump activity in hypertrophied canine ventricular cells Cardiovasc Res, March 15, 2003; 57(4): 1035 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Sipido, P. G.A Volders, M. A Vos, and F. Verdonck Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res, March 1, 2002; 53(4): 782 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Verduyn, C. Ramakers, G. Snoep, J. D. M. Leunissen, H. J. J. Wellens, and M. A. Vos Time course of structural adaptations in chronic AV block dogs: evidence for differential ventricular remodeling Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2882 - H2890. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Babuty and M. J Lab Mechanoelectric contributions to sudden cardiac death Cardiovasc Res, May 1, 2001; 50(2): 270 - 279. [Full Text] [PDF] |
||||
![]() |
J.M van Opstal, S.C Verduyn, H.D.M Leunissen, S.H.M de Groot, H.J.J Wellens, and M.A Vos Electrophysiological parameters indicative of sudden cardiac death in the dog with chronic complete AV-block Cardiovasc Res, May 1, 2001; 50(2): 354 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Verduyn, J. M. v. Opstal, J. D. Leunissen, and M. A. Vos Assessment of the Pro-Arrhythmic Potential of Anti-Arrhythmic Drugs: An Experimental Approach Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 89 - 97. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |